Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Industry News

    BARDA Awards Medical Countermeasure Clinical Studies Network Contracts

    By Global Biodefense StaffMarch 26, 2014
    Share
    Facebook LinkedIn Reddit Email

    The Biomedical Advanced Research and Development Authority (BARDA) has recently awarded five indefinite delivery, indefinite quantity (IDIQ) contracts in support of the Medical Countermeasure Clinical Studies Network.

    The goal of the network is to generate clinical trial data that will evaluate medical countermeasures, such as vaccines, therapeutics, diagnostics and medical devices. 

    The awardees will provide a full range of services including statistical expertise and project management, study design and protocol development, data collection, and data analysis and reporting.  The two-year contracts, which includes three one-year options, each have a ceiling of $100 million and a minimum order guarantee of $400,000.

    The following organizations were awarded the IDIQ contracts:

    • Clinical Research Management, Inc.
    • The EMMES Corporation
    • PPD Development
    • Rho Federal Systems Division, Inc.
    • Technical Resources International, Inc.

    Studies performed by this network will clinically evaluate Chemical, Biological, Radiological, Nuclear (CBRN), pandemic influenza and emerging infectious disease medical countermeasures. These studies may be Phase 1, 2, 3, or 4 or combinations of such.

    Source: RFP-13-100-SOL-00008 (FBO.gov)

    ASPR Awards BARDA HHS Pandemic Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNotable Contracts: IITRI Biological Surety Support for Plague Vaccine
    Next Article Testing Rules Out Ebola in Canadian Patient

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023

    Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve

    September 13, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.